Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Clinical trial NCT06398977 · RECRUITING

Trial details

NCT number: NCT06398977
Sponsor: Sichuan Academy of Medical Sciences
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Peritoneal Dialysis Complication Renal Function Aggravated Sodium-glucose Co-transporter-2 Inhibitors

Start date: 2024-03-11
Primary completion: 2026-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.